Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Oncotarget|April 27, 2017
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicityNavid Koleini, Elissavet KardamiMolecular and Cellular Biochemistry|May 24, 2006
Regulation of connexin-43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming abilityXitong Dang, Madhumathy Jeyaraman, Elissavet KardamiMolecular and Cellular Biochemistry|March 7, 2003
The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growthXitong Dang, Bradley W Doble, Elissavet KardamiFrontiers in Pharmacology|July 25, 2013
Together and apart: inhibition of DNA synthesis by connexin-43 and its relationship to transforming growth factor βMaya M Jeyaraman, Robert R Fandrich, Elissavet KardamiCanadian Journal of Physiology and Pharmacology|January 13, 2005
Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2Karen A Detillieux, Peter A Cattini, Elissavet KardamiNeuroscience Letters|August 23, 2016
Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neuronsYong Cheng, Zhaojin Li, Elissavet Kardami, et al.Journal of Molecular and Cellular Cardiology|December 4, 2018
Do different nuclei in a binucleated cardiomyocyte have different rates of nuclear protein import?Marketa Hlavackova, Elissavet Kardami, Robert Fandrich, et al.Cardiovascular Research|December 31, 2002
Biological activities of fibroblast growth factor-2 in the adult myocardiumKaren A Detillieux, Farah Sheikh, Elissavet Kardami, et al.Cardiovascular Toxicology|February 23, 2013
FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunctionDavid P Sontag, Jie Wang, Elissavet Kardami, et al.Cardiovascular Research|January 24, 2013
FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transportersJie Wang, Mark W Nachtigal, Elissavet Kardami, et al.Pageof 6